HYTERRA LTD — Board/Management Information 2008

Jul 16, 2008

==> picture [116 x 105] intentionally omitted <==

==> picture [102 x 21] intentionally omitted <==

----- Start of picture text ----- www.brainz.com ARBN 116 829 675----- End of picture text -----

ASX Announcement

Board Change

17 July 2008: BrainZ Instruments (ASX:BZI) announced today Dr Robin Congreve has resigned his position as director of the company.

BrainZ would like to thank Robin for his hard work and contribution to the company. We wish him best in his future endeavours.

Inquiries:

Richard Smith Chief Executive Officer BrainZ +1 443 280 2920

Rudi Michelson Monsoon Communications 03 9620 3333

About BrainZ

BrainZ (ASX: BZI) is a New Zealand based medical technology company specializing in the research, development, manufacturing and sale of bedside brain monitoring technology. The BRM3 Brain Monitor, BrainZ’s second generation product, is a unique bedside tool that assists in the detection of brain injury and seizure activity in neonates. It has been specifically designed to assist intensive care staff with clinical decision-making in conjunction with other clinical data and in the direction of care on a day-today basis.

The BRM3 has received regulatory approval in most major markets and is in use in over 20 countries worldwide. BrainZ dominates the local Australian and New Zealand markets via direct sales channels. BRM2 monitors are also installed in over 40 leading US hospitals. BrainZ has an exclusive agreement with GE Healthcare, a leading supplier of patient monitoring systems, for the distribution of BRM3 Brain Monitors in the North American, European, Middle East and Asian markets.

BrainZ Instruments was established in 2001 to commercialize pioneering neonatal brain research from the Auckland University’s Liggins Institute.